Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ron Bentsur Insider Profile
11 Followers
Ron Bentsur, CEO, Director at Keryx Biopharma, holds 3.25M shares in Nuvectis Pharma (Ticker: NVCT), holds 144.74K shares in Beyond Air (Ticker: XAIR), holds 0.00 shares in Stemline Therapeutics (Ticker: STML). Most recently, Ron Bentsur Bought ― shares of Nuvectis Pharma on May 15, 2024 for an estimated value of 13.08K.
Profitable Transactions
33 out of 57 Profitable Transactions
Average Return
+11.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Ron Bentsur holds in companies
Most Profitable Insider Trade
The most profitable trade made by Ron Bentsur
Ron Bentsur's Trading History
Keryx Biopharma
Apr 08, 2015
―
Informative Sell
18.59K
$2.61M
Beyond Air
Mar 21, 2023
Director
Informative Buy
14.90K
$71.50K
Nuvectis Pharma
May 15, 2024
Chairman & CEO, Director, Ten Percent Owner
Informative Buy
13.08K
$35.65M
Stemline Therapeutics
Jun 10, 2020
―
Uninformative Sell
―
$0.00
XTL Biopharmaceuticals Ltd. Sponsored ADR
―
CEO
―
$37.59K
List of latest transactions for each holding click on a transaction to see Ron Bentsur's performance on stock
You May Also Like
Ron Bentsur insider profile FAQ
What is the percentage of profitable transactions made by Ron Bentsur?
The percentage of profitable transactions made by Ron Bentsur is 58%.
What is the average return per transaction made by Ron Bentsur?
The average return per transaction made by Ron Bentsur is 11.60%.
What stocks does Ron Bentsur hold?
Ron Bentsur holds: KERX, XAIR, NVCT, STML, XTLB stocks.
What was Ron Bentsur’s latest transaction?
Ron Bentsur latest transaction was an Informative Buy of $13.08K.
What was Ron Bentsur's most profitable transaction?
Ron Bentsur’s most profitable transaction was an Informative Buy of NVCT stock on February 11, 2022. The return on the trade was 107.00%.
What is Ron Bentsur's role in Keryx Biopharma?
Ron Bentsur's role in Keryx Biopharma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.